bse

  1. A

    Vedanta Raises Capital Through Unsecured Debentures

    New Delhi, February 26 The Board of Directors of Vedanta Ltd has approved raising up to ₹3,000 crore through debentures through a private placement.The fundraising aims to further strengthen the company's capital structure while optimizing borrowing costs.The company has informed stock...
  2. S

    IRFC Share Price Drops as OFS Subscription Exceeds Expectations

    New Delhi, February 25 The government's offer to sell 2% of its stake in Indian Railway Finance Corporation Ltd (IRFC) failed to attract full subscription from institutional investors on Wednesday.Institutional investors placed bids for over 22.34 crore shares of IRFC, which represents 94.98%...
  3. S

    Government's IRFC Stake Sale Partially Subscribed by Institutions

    New Delhi, February 25 The government's offer to sell 2% of its stake in Indian Railway Finance Corporation Ltd (IRFC) received a lukewarm response from institutional investors on Wednesday, as the issue failed to achieve full subscription.As of 3:30 PM, institutional investors placed bids for...
  4. P

    Lupin Launches Generic Seizure Treatment in the US

    New Delhi, February 25 Drug firm Lupin announced on Wednesday that it has received approval from the US health regulator to market a generic medication to treat seizures.The Mumbai-based firm has received approval from the USFDA for its abbreviated new drug application (ANDA) for Brivaracetam...
  5. S

    India's Government Divests in IRFC Through Offer for Sale

    New Delhi, February 24 The government will divest up to 4% stake in state-owned Indian Railway Finance Corporation Ltd (IRFC) through an Offer for Sale (OFS) starting on Wednesday.The government has fixed the floor price of Rs 104.00 per equity share for the OFS, IRFC said in a regulatory...
  6. S

    Government to Sell IRFC Stake, Raising Over Rs 5,000 Crore

    New Delhi, February 24 The government will sell up to 4% stake in Indian Railway Finance Corporation (IRFC) through a sale offer at a floor price of Rs 104 per share.The sale offer will open on Wednesday for institutional investors, and on Thursday for retail investors.The government is...
  7. H

    No Enforcement Action Recommended in Dr. Reddy's SEC Probe

    New Delhi, February 24 Dr. Reddy's Laboratories said on Tuesday that the U.S. Securities and Exchange Commission has not recommended any enforcement action against it due to an anonymous complaint alleging improper payments to healthcare professionals in Ukraine and other countries.The...
  8. A

    Market Opportunity for Efinaconazole as Alembic Pharma Gains USFDA Nod

    New Delhi, February 24 Alembic Pharmaceuticals announced on Tuesday that it has received approval from the US health regulator to market a generic antifungal medication.The company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution...
  9. R

    Indian Markets React to Trade Worries and AI Uncertainty

    Mumbai, February 24 – The Sensex and Nifty benchmark indices tumbled by more than 1% on Tuesday, driven by heavy losses in IT stocks amid concerns over disruption caused by artificial intelligence and renewed trade-related uncertainties.Rising global crude prices, fueled by escalating US-Iran...
  10. V

    Indian Markets React to Global Uncertainty and AI Disruptions

    Mumbai, February 24 The benchmark equity indices, Sensex and Nifty, fell by more than 1% on Tuesday, dragged down by heavy losses in IT stocks amid concerns over disruption caused by artificial intelligence and renewed uncertainties related to trade.Rising global crude prices, coupled with...
  11. T

    Diamond Jewellery Retailer PNGS Reva IPO Set to Launch

    New Delhi, February 23 PNGS Reva Diamond Jewellery announced on Monday that it has raised nearly Rs 171 crore from anchor investors ahead of its initial public offering.The foreign and domestic institutions that participated in the anchor round included Citigroup Global Markets Mauritius...
  12. P

    Ranluspec Approval: Lupin's Biosimilar for Eye Conditions Gains EU Clearance

    New Delhi, February 23 Drug maker Lupin announced on Monday that it has received approval from the European Commission for its biosimilar for the treatment of various eye conditions.The company has received approval for Ranluspec (ranibizumab), following the recent positive opinion from the...
  13. S

    Investors Cheer US Court Verdict, Driving Sensex Gains

    Mumbai, February 23 – The Sensex and Nifty indices closed higher on Monday, driven by gains in PSU banks, auto, and financial stocks, as investor sentiment improved following the US Supreme Court's ruling against the Trump administration's tariffs.The 30-share BSE Sensex climbed 479.95 points...
  14. P

    Indian Markets Fall as Geopolitical Uncertainty Persists

    Mumbai, February 19 The benchmark Sensex fell by 1,236 points or 1.5 per cent, while the Nifty closed near 25,450 on Thursday, following a broad sell-off amid escalating geopolitical tensions between the US and Iran.Halting a three-day winning streak, the 30-share BSE Sensex plunged 1,236.11...
  15. V

    Dr. Reddy's Expands into Hormone Replacement Therapy Market

    New Delhi, February 19 Dr. Reddy's Laboratories has entered the hormone replacement therapy segment by acquiring the trademarks of specialty brands, Progynova and Cyclo-Progynova, and related assets for India from UK-based Mercury Pharma Group for USD 32.15 million, according to a company...
  16. R

    Indian Markets Extend Rally: Key Sectors Drive Positive Momentum

    Mumbai, February 18 – The Sensex and Nifty indices rose for the third consecutive trading day on Wednesday, driven by late-day buying in shares of banks, metal companies, and FMCG firms.The 30-share BSE Sensex gained 283.29 points, or 0.34%, to close at 83,734.25. During the day, it touched an...
  17. A

    Investor Demand Drives IIFL Finance NCD Subscription

    New Delhi, February 17 IIFL Finance Ltd, a NBFC firm, announced on Tuesday that the initial offering of its secured, redeemable, non-convertible debentures (NCDs) had been fully subscribed within the first half of the opening day.This reflects strong investor demand and confidence in the...
  18. A

    Aye Finance IPO Listing: Stock Performance Details

    New Delhi, February 16 Shares of the non-banking financial company (NBFC) Aye Finance ended marginally lower on Monday, marking a subdued market debut against the issue price of Rs 129.The stock is listed at Rs 129 per share on both the NSE and the BSE. During the trading session, it reached a...
  19. H

    Reva Diamond IPO: Price Band Set at ₹367-₹386

    New Delhi, February 16 PNGS Reva Diamond Jewellery has fixed a price band of ₹367 to ₹386 for its ₹380-crore initial public offering (IPO).The initial share sale will open for public subscription on February 24 and conclude on February 26, while bidding for anchor investors will take place on...
  20. S

    Q3 Results: Patel Engineering Net Profit Down Rs 72 Crore

    New Delhi, February 16 Patel Engineering has reported a 12.2 per cent decline in consolidated net profit at Rs 71.5 crore for the quarter ended December 31, 2023.The infrastructure and construction services firm had posted a net profit of Rs 81.5 crore for the year-ago period.Total income...
Back
Top